0001, QFT reagents and control

Ended Indefinite Delivery Contract Awarded Last action

Contract number
W81K0220D0020
Awardee
Awarding agency
Task orders
5 $389,149 obligated

Award facts

Opportunity
Combined order value
$389,149 Current and potential, with all options
Last date to order 100% complete
IDV ceiling 99% used
$391,649.00
Award type
Single award
Who can order
Only the awarding agency
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
6 offers Simplified Acquisition
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

This federal contract IDV was awarded by the Defense Health Agency (DHA), a defense agency, to Qiagen, LLC, a subsidiary of the international diagnostics company Qiagen N.V. The $391,649 single-award indefinite delivery contract, with a period of performance through September 2025, aims to provide the DHA with QFT reagents and controls to support tuberculosis testing programs at military treatment facilities.

Under this IDV, DHA has issued multiple delivery orders to Qiagen for the provision of QuantiFERON-TB Plus reagents, as well as a lease and reagent supply contract for instrumentation to detect infectious disease immune responses. These orders, valued up to $83,000 each, will be fulfilled at the Madigan Army Medical Center in Washington state to aid the Army Medical Command's tuberculosis diagnosis and monitoring efforts. No set-aside designations were applied to this IDV or associated task orders.

Task orders

Transactions

Action Obligated Date
Exercise an Option P00008 · Modification - exercise option (4) - QFT reagents and controls $0
Other Administrative Action P00007 · Modification - admin MOD - 2001, QFT reagents and control $0
Supplemental Agreement for work within scope P00006 · QFT reagents and control, add far clause 52.204-27 no TIK-TOK clause $0
Exercise an Option P00005 · Modification - exercise option (3) - 2001, QFT reagents and control $0
Supplemental Agreement for work within scope P00004 · QFT reagents and control - UOM changes to OPT 3 and 4 $0
Exercise an Option P00003 · A cost per test, lease, contract for reagents and automated or semi-automated instrumentation for the detection of infectious disease immune responses. $0
Supplemental Agreement for work within scope P00002 · Modification to increase quantity to clins 1001, 2001, 3001 and 4001. $0
Exercise an Option P00001 · 1001, QFT reagents and control $0
Original award $0

Quick answers

Who was awarded contract W81K0220D0020?

W81K0220D0020 was awarded to Qiagen, LLC by Medical Command (Department of the Army) on October 1, 2020.

How much is contract W81K0220D0020 worth?

Orders under W81K0220D0020 have obligated $389,149. W81K0220D0020's own ceiling is $391,649.

How many orders have been placed under contract W81K0220D0020?

5 orders have been placed under W81K0220D0020, the latest on October 1, 2024.

Which agency awarded contract W81K0220D0020?

Medical Command (Department of the Army) awarded W81K0220D0020, with funding from Defense Health Agency (Department of Defense).

Who can order from contract W81K0220D0020?

W81K0220D0020 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract W81K0220D0020 competed?

The government received 6 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV